Capital Ideas
ResearchGet Premium

ACCESS THE LATEST RESEARCH AND INSIGHTS

UNCOVERING A HIDDEN GEM

Access the new Digest for a pharmaceutical company we’ve detected that’s quietly growing its revenue at 400%, EBITDA positive, and has $30 million in cash.

UNCOVERING A HIDDEN GEM

Access the new Digest for a pharmaceutical company we’ve detected that’s quietly growing its revenue at 400%, EBITDA positive, and has $30 million in cash.


UNDERVALUED PHARMA’S GROWTH POTENTIAL HIDING IN PLAIN SIGHT

Also inside: Retailer proves there’s life in brick and mortar with 25% upside.

Plus: Best performing investment letter of last 30 years chooses five value dividend stocks.

UNDERVALUED PHARMA’S GROWTH POTENTIAL HIDING IN PLAIN SIGHT

Also inside: Retailer proves there’s life in brick and mortar with 25% upside.

Plus: Best performing investment letter of last 30 years chooses five value dividend stocks.


UNHERALDED PHARMA COULD GAIN 180%

Today’s new Capital Ideas Digest unveils a Canadian pharma company that is growing revenue at more than 400% and is EBITDA positive. More investors need to know about this stock.

UNHERALDED PHARMA COULD GAIN 180%

Today’s new Capital Ideas Digest unveils a Canadian pharma company that is growing revenue at more than 400% and is EBITDA positive. More investors need to know about this stock.


CONSTELLATION OWNS ITS CANOPY LOSSES

CONSTELLATION OWNS ITS CANOPY LOSSES


CARGOJET DEEPENS AMAZON TIES

Keep reading for details of Cargojet’s deal with Amazon.com and a Canadian pharma growing revenue at more than 400%.

CARGOJET DEEPENS AMAZON TIES

Keep reading for details of Cargojet’s deal with Amazon.com and a Canadian pharma growing revenue at more than 400%.


OIL & GAS COMPANY WITH INTERNATIONAL EXPOSURE COULD GAIN 48%

OIL & GAS COMPANY WITH INTERNATIONAL EXPOSURE COULD GAIN 48%


FIVE MID-CAP GROWTH STOCKS

Check out the new Digest for five mid-cap growth stocks, and the one cannabis producer to own after earnings that were “the best ever for a Canadian cannabis company.”

FIVE MID-CAP GROWTH STOCKS

Check out the new Digest for five mid-cap growth stocks, and the one cannabis producer to own after earnings that were “the best ever for a Canadian cannabis company.”


What’s the Yield Curve Really Predicting?

Also inside: Why this company could gain 260% after its earnings were “the best ever by a Canadian cannabis company.”

Plus: Five mid-cap growth stocks from Morningstar.

What’s the Yield Curve Really Predicting?

Also inside: Why this company could gain 260% after its earnings were “the best ever by a Canadian cannabis company.”

Plus: Five mid-cap growth stocks from Morningstar.



Error X
Your e-mails don't match.
Close